PERSPECTA

News from every angle

← Back to headlines

Repligen Projects 2026 Revenue and EPS Amid BioLife Deal

Repligen projects 2026 revenue between $813M-$834M and raised EPS to $2.03-$2.09, following its BioLife deal.

28 Jul, 17:24 — 28 Jul, 17:24
PostShare

Sources

Showing 1 of 1 sources
seeking-alphaMixed7h ago

Repligen projects $813M-$834M 2026 revenue amid BioLife deal and raised $2.03-$2.09 EPS

Read full article →

Related Stories

Explosive Attacks Decline in Netherlands After Years of Increase

just now

Five Bosnian Mountaineers Die on Mount Elbrus, Day of Mourning Declared

just now

Fire breaks out in Tondo, Manila residential area

just now

LPA Brings Rains and Class Suspensions Across Philippines on July 29

just now